Hospital practices concerning the in-use storage time of (reconstituted) oncology medicines
Dear BOPA Members,
The EDQM (the European Directorate for the Quality of Medicines&Healthcare of the Council of Europe) is conducting a survey following a study from national monitoring activities, which revealed that some hospital pharmacies assign longer in-use storage times to reconstituted anticancer medicines than those specified in the marketing authorisation and summary of product characteristics (SmPC).
The aim of the survey is to assess how common these practices are across Europe, to identify the sources used to justify extended storage times, and to understand the rationale behind them. The final objective is to map current practices and evaluate the potential need for guidance to ensure the safe use of reconstituted medicines.
Your contributions would be extremely valuable to provide EDQM with a comprehensive overview of the situation across Europe. To contribute you can use the following link:
https://survey.edqm.eu/index.php?r=survey/index&sid=751574&lang=en
The deadline for submission is 08 November 2024.
The EDQM assured that the responses will remain confidential.
Thank you for your collaboration.
Lead Policy Officer
European Association of Hospital Pharmacists (EAHP)
